title: JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders.
authors.forename: N
authors.initials: N
authors.lastname: Cambier
authors.forename: A
authors.initials: A
authors.lastname: Renneville
authors.forename: T
authors.initials: T
authors.lastname: Cazaentre
authors.forename: V
authors.initials: V
authors.lastname: Soenen
authors.forename: C
authors.initials: C
authors.lastname: Cossement
authors.forename: S
authors.initials: S
authors.lastname: Giraudier
authors.forename: N
authors.initials: N
authors.lastname: Grardel
authors.forename: J-L
authors.initials: JL
authors.lastname: Laï
authors.forename: C
authors.initials: C
authors.lastname: Rose
authors.forename: C
authors.initials: C
authors.lastname: Preudhomme
mesh_terms: D001549:Benzamides; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D053614:Janus Kinase 2 / Q000235:genetics*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010879:Piperazines / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000150:complications / Q000235:genetics*; D011743:Pyrimidines / Q000627:therapeutic use
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl; C507924:JAK2 protein, human; D053614:Janus Kinase 2